PELL BIO-MED TECHNOLOGY CO., LTD. — Proxy Solicitation & Information Statement 2026

May 18, 2026

PELL BIO-MED TECHNOLOGY CO. LTD

Notice of Annual Shareholders’ Meeting 2026

(Summary Translation)

The 2026 Annual Shareholders’ Meeting (the “Meeting”) of Pell Bio-Med Technology Co.Ltd (the “Company”) will be convened at 9:00 a.m., Thursday, June 18, 2026 at No. 158, Xingshan Road, Neihu, Taipei City 114, Taiwan.

The agenda for the Meeting is as follows:

I. Report Items

1. 2025 Business Report.
2. Robust Operations Plan Implementation Status Report
3. 2025 Audit Committee's Review Report.
4. Accumulated loss incurred by a company aggregates to one half of its paid-in capital.
5. Proposal for the amendment to the "Sustainable Development Principles"
6. Proposal for the amendment to the " Rules of Procedure for Board of Directors Meetings"

II. Matters for Ratification

1. 2025 Business Report and Financial Statements.
2. 2025 Deficit compensation proposal.

III. Matters for Discussion

1. Amendment of the Company’s Articles of Incorporation.
2. Proposal for the Issuance of Restricted Stock to Employees.
3. Amendment of the “Procedure for Handling the Acquisition and Disposal of Assets”
4. Amendment of the “Procedure for Loaning Funds to Others”
5. Amendment of the “Procedure for Making of Endorsements/Guarantees”
6. Amendment of the “Regulations Governing the Handling of Derivative Products Transactions”
7. Amendment of the “Procedure for Election of Directors”
8. Amendment of the “Rules of Procedure for Shareholders' Meetings”
9. Amendment of the “Rules of Procedure for Shareholders' Meetings”

IV. Extemporary Motions

V. Adjournment